The new methods which are currently available have provided substantial hel
p in performing the differential diagnosis of CPP, especially in detecting
very early modifications of gonadotropin secretion. Nocturnal sampling is n
ot a practical tool and generates discomfort for patients, and daytime samp
les do not yet have sufficient sensitivity; thus, determination of LH level
s after GnRH stimulation is the most important test. We emphasize that the
use of the GnRH agonist test improves the discrimination of the endocrine i
nvestigation, making it easier to differentiate CPP from other conditions,
such necessary, but its use in isolation is not as thelarche, Determination
of sex steroids is recommended.